Selecting A Test Method For Your Container System

When Unexpected Particles Threaten Your Biologic

Controlling Nitrosamine Risk In Drug Products: Detection, Formation, And Control Strategies

Enhancing AAV Manufacturing Yield Via Mini-Helper Plasmid

When High-Stakes ADC Decisions Can't Wait for More Material or Better Data

Modular VFlexible Aseptic Filling Lines

Breaking the Titer Ceiling: Smarter Media Design for Higher Productivity

Automating Cell Therapy Manufacturing Without Redesigning Workflows

Smarter DNA, Healthier Cells

Creative Chromatography Solutions For Complex Small Molecules

Solving Formulation Challenges Across Modalities

Fostering A Collaborative, Cross-Functional Approach

Cambrex Scientist Spotlight: Kelly McGuill

Chromatography, Purification & Isolation Technologies

Rapid, Material-Sparing Feasibility Screening For Hot Melt Extrusion

The Paradigm Shift To Continuous Flow Processes: A Holistic View

How To Design An HPAPI Plant And Its Containment Systems

Future Of Pharma Packaging: Trends, Tech, And Patient Solutions

Understanding FDA Calibration Requirements And Best Practices For Reducing Risks

New Approaches To Tailored Release Profiles

Considerations For Complex Formulations: How To Simplify Your Outsourcing

Managing Nitrite Impurities: Supplier-Manufacturer View

Overcoming Obstacles On The Journey To Commercialization

Accelerate Your AAV Journey To IND And Beyond

AAV Analytics: Key Considerations When Developing A Clinical Program

Early Preclinical Development: A Successful Transition To cGMP Manufacturing

Accelerate Development And De-Risk Gene Therapy Manufacturing

Cell & Gene Therapy Development: Characterization Of Cellular Starting Material

Selecting The Right CMO For Your Gene Therapy

The Journey To Safety Through Viral Clearance

Viral Safety Of Biologics: What's Changing With The ICH Q5A Revision?

A Transformative Journey From Research To Large-Scale Production

A Robust And Scalable Suspension Platform For AAV Manufacturing

Explore What's Next: Product Characterization

Eliminate Risk From Your Viral Vector Tech Transfers

Resilience Capabilities Update July 2026: Fill/Finish

Rentschler Biopharma Capabilities Update July 2026: Large Molecule

Avid Bioservices Capabilities Update July 2026: Large Molecule

Samsung Biologics Capabilities Update July 2026: Large Molecule

Thermo Fisher Scientific Capabilities Update July 2026: Fill/Finish

KBI BioPharma Capabilities Update July 2026: Large Molecule

AbbVie Capabilities Update July 2026: Large Molecule

Pace Life Sciences Capabilities Update July 2026: Fill/ Finish

Ardena Capabilities Update July 2026: Fill/Finish

Resilience Capabilities Update May 2026: Large Molecule

Rentschler Biopharma Capabilities Update May 2026: Large Molecule

Samsung Biologics Capabilities Update May 2026: Large Molecule

MilliporeSigma Bio-Expo Live 2024: Quality, Data, & Analytical Solutions

Selecting The Right CMO For Your Gene Therapy

Flexible Manufacturing That Fits Your Molecule

Explore What's Next: Product Characterization

New Approaches To Tailored Release Profiles

KBI Biopharma Capacity Update October 2025: Analytical Services

MilliporeSigma Capacity Update October 2025: ADC

Biotherapy Characterization: Cell-Based Assays

Introducing The MAST® Autosampling Solution

ICH Q7 Good Manufacturing Practice Guide For Active Pharmaceutical Ingredients

GLP And The Impact To Start Up Companies

The Minimum Package A CDMO Needs To See

Repeating An Experiment Is Not Quality Control

When Is It Too Early To Engage A CDMO?

The Missing Data That Can Send A Program Back To The Bench

CDMO Readiness Is More Than A Data Package

Charting A Direct Pathway From Academia To CDMOs

Match The CDMO To The Stage Of Development

Are You Really Ready To Transfer?

The Data Package Blind Spots That Create Surprises

Tech Transfer Is Not A Handoff

Tech Transfer Is More Than A Batch Record

Beyond Data Packages: Derisking Tech Transfer To CDMOs

Annex 1 FAQs: How Are We Responding To Provide Confidence For Customers?

Managing Multiple Partners – And Materials – From Around The Globe

Start With An Integrated, Verified PFS System

Workforce Challenges Key To Outsourcing

Annex 1 FAQs: How Do You Understand Risk Regarding Contamination Control?

Start Packaging Development Early

Annex 1 FAQs: Why Is A Good Supplier Partnership Pivotal To Meet Regulatory Expectations?

Annex 1 FAQs: How Is Behavior Changing As A Result Of EU GMP Annex 1?

Collaborating To Craft Efficient Processes

Annex 1 FAQs: Responding To The 2022 Revision

Planning For Scale-Up

Selecting A CDMO: A Guide To Successful Collaboration

Protecting Your Drug Product

Establishing A Container Closure System

Delivering Top Quality Fill Finish Manufacturing

Minimizing Particulate Risk

Efficient, Single-Source PFS Supply

Accountability For The Whole PFS System

Annex 1 FAQs: What Was The Biggest Challenge With EU GMP Annex 1?

Fostering CDMO Collaboration On Both Sides

Streamline Your Path To Clinical Fill

Redefining Prefillable Syringe System

Consistent, Reliable, High-Quality Components

Annex 1 FAQs: How Are We Responding To Foster Trust With Customers?

Visionary Thinkers And Problem Solvers: The Cambrex Team

Picking Biotech Winners Beyond The Hype Cycle With Andera Partners' Olivier Litzka

Biotech Investing At The Earliest Stages With Santé Ventures' Omar Khalil

Getting To A First Product Approval With Celcuity's Brian Sullivan

Cell Therapy Advances And Biotech Leadership With Nkarta's Paul Hastings

A Rescue Model For Shelved Drug Candidates With Annette Bakker, Ph.D. And Andrew Lo, Ph.D.

Using Genetics To Discover New Treatments With Regeneron Genetics Center's Aris Baras, M.D.

Late-Stage Development And Commercial Planning With CervoMed's Matt Winton, Ph.D.

BoB@BIO: Biotech In The Balance With Ovid Therapeutics' Dr. Jeremy Levin

BoB@BIO: Biotech Investing And Deals With Sofinnova's Maha Radhakrishnan, M.D.

Targeting Tau in Alzheimer's Disease With Voyager Therapeutics' Al Sandrock, M.D., Ph.D.

Keeping An Early-Stage Cell Therapy Biotech In The Black With IN8bio's William Ho

Drug Launch Success In A Changing Commercial Landscape With ACMA's William Soliman, Ph.D.

The Editors' Roundtable: A Midyear Look At The 2026 Life Sciences Industry

Derisking CNS Drug Development With Tortugas Neuroscience's Jeff Jonas, M.D.

Rare Disease Drug Commercialization With Zevra Therapeutics' Neil McFarlane

Scaling Manufacturing For Personalized Cell Therapies With Cellino's Marinna Madrid, Ph.D.

Building A New Antibody Discovery Platform With Infinimmune's Wyatt McDonnell, Ph.D.

From Partnered ASO Therapies To A Wholly-Owned Pipeline With Ionis's Brett Monia, Ph.D.

Implementing A New CEO Strategy With NervGen's Adam Rogers, M.D. And Rich Macary

The Impact Of FDA Risk On Biotech Rewards With CFO And Board Director Allan Shaw

Biosimilars And Complex Medicines For All With RNA Therapeutics' Sarfaraz Niazi, Ph.D.

Radiotherapeutics For Neuroendocrine Tumors With Perspective Therapeutics' Thijs Spoor

Investing In Early-Stage Oncology With Yosemite's Dan McHugh

Commercializing CAR T Cell Therapy With Legend Biotech's Alan Bash

Radiotherapeutics For CNS Cancers With Plus Therapeutics' Marc Hedrick, M.D.

Developing Novel Cancer Drugs On A Budget With Iterion Therapeutics' Rahul Aras, Ph.D.

Making Biologics Orally Available With Vivtex's Thomas von Erlach, Ph.D.

An Anthropological Lens On Leadership In Life Sciences With Bunka's Monika Sumra, Ph.D.

Company Turnarounds And AI For Infectious Diseases With Seek Labs' Jared Bauer

Bringing Curative Cell Therapies To Market with Kite Pharma's Cindy Perettie

BoB@JPM: Brian Hilberdink, Boehringer Ingelheim

BoB@JPM: Ron Cooper, enGene

BoB@JPM: Marc Salzberg, M.D., Airway Therapeutics

A Royalty Model For Value Creation With Zymeworks' Kenneth Galbraith

Life Science Connect Editors' Roundtable: Wrapping Up 2025 And Looking Ahead

Building Cell Therapy Companies With Kenai Therapeutics' Nick Manusos

Modernizing Clinical Trial Operations With Merck's Jennifer Sheller

Transforming Chronic Kidney Disease With ProKidney's Bruce Culleton, M.D.

Engineering B Cells With Immusoft's Sean Ainsworth

Building A Cancer Pipeline In A Molecule With Actuate Therapeutics' Dan Schmitt

Biotech Collaboration Strategy With IGI's Cyril Konto, M.D.

Biotech Funding And IPO Temperature Check With CREATE Medicine's Allan Shaw

Funding Tips And Moving From R&D To Commercial With Madrigal Pharmaceuticals' Mardi Dier

Emerging From Stealth With Vima Therapeutics' Bernard Ravina, M.D.

BoB in South Florida: Rich Daly, Catalyst Pharmaceuticals

BoB In South Florida: Anthony Japour, M.D., iTolerance

BoB In South Florida: Daniel Teper, NAYA Therapeutics

BoB In South Florida: Raquel Cabo, Miami Biotech Collective

The Business Case For Health Economics And Outcomes Research With ISPOR's Rob Abbott

Cannabinoid And Psychedelic Combinations With Incannex Healthcare's Joel Latham

Dye Drug Conjugates For Cancer With Lahjavida's Lyle Small

Investing In The Biostack With Modi Ventures' Sahir Ali, Ph.D.

Improving Cardiovascular Outcomes With Immediate Therapeutics' Atul Deshpande, Ph.D.

Building A Biotech Incubator And Accelerator With Swiss Rockets Founder And CEO Vladimir Cmiljanovic, Ph.D.

Biotech Product Partnership with Coya Therapeutics' Arun Swaminathan, Ph.D. and Dr. Reddy's Milan Kalawadia

How To Hire And Build A Winning Executive Team With Occam Global's Bill Holodnak

The Generalist Biotech CEO With Seekyo's Oury Chetboun

Innovating On The Frontier Of Radiopharmaceuticals With RadioMedix's Ebrahim Delpassand, M.D.

Building An Efficient Biopharma With South Rampart Pharma's Hernan Bazan, M.D.

The Business And Science Of Obesity With Roger Cone, Ph.D., Founder Of Courage Therapeutics

BoB Live At BIO: Amber Salzman, Ph.D., Epicrispr Biotechnologies

How To Be A Policy Advocate For Biotech With NewYorkBIO's Jennifer Hawks Bland

FDA Trials And Tribulations With Connect Biopharma's Barry Quart

Proactive Procurement Strategies For Biotech With Tom Wells

The Discovery Of Microbes And Implications For Public Health Today, With Science Writer Thomas Levenson

Psychedelics For Mental Health Disorders With atai's Srinivas Rao, M.D., Ph.D.

Biotech Angel Investing With Yaniv Sneor

Leading A tRNA Startup With Alltrna's Michelle Werner

Executing A Product Pivot With Vir's Mark Eisner, MD

Commercializing RNAi Therapies With Alnylam's Tolga Tanguler

Big Pharma Insights For Building Biotech Startups With Uniquity Bio's Brian Lortie

The Implications Of China's Growing Biotech Industry With Allan Shaw

How To Be A CFO With Insmed's Sara Bonstein

Deal And Investment Trends With Investment Banker David Sans

Business of Biotech 2.0 with Ben Comer

BoB@JPM: Nima Farzan, Latigo Biotherapeutics

BoB@JPM: Kasper Roet, Ph.D., QurAlis

BoB@JPM: Rick Modi, Affinia Therapeutics

BoB@JPM: Owen Hughes & Brad Sitko, XOMA Royalty

BoB@JPM: Tom Chalberg, Ph.D., Genascence

BoB@JPM: Ran Zheng, Landmark Bio

BoB@JPM: Peter Anastasiou, Capsida Biotherapeutics

BoB@JPM: Stefan Scherer, M.D., Ph.D., 3T Bioscience

The Business Of CNS with Acumen's Jim Doherty, Ph.D.

High-Throughput Discovery With BIOPTIC's Andrey Dobry

RNA Sandbox with Johns Hopkins RNA Innovation Center's Jeff Coller, Ph.D. and Michelle Kim, Ph.D.

Biotech Story Time With Tal Zaks, M.D. (Part 2)

Risk Mitigation With MeiraGTx's Zandy Forbes, Ph.D.

Biotech Story Time With Tal Zaks, M.D. (Part 1)

A $1B AI Bet With Foresite Labs' Vik Bajaj, Ph.D.

Manufacturing Partnership With Life Biosciences Jerry McLaughlin and Forge Biologics' John Maslowski

Novel Peptide Delivery With Revolo's Woody Bryan, Ph.D.

Biopolitics With Allan Shaw

T-Cells For The Win With Adaptimmune's Adrian Rawcliffe

Serving The Underserved With Gates MRI's Claire Wagner, M.D.

An Unanticipated Biotech Startup With OS Therapies' Paul Romness

Building On Pandemic Progress With Barinthus Biotherapeutics' Bill Enright

Obesity Tx End-Around With Skye Bioscience's Punit Dhillon

Biotech C-Suite Construction With Allan Shaw

The Peptide Promise With NervGen's Mike Kelly

Why Autoimmune CAR T Needs a New Patient-Centered Playbook with Dr. Panteli Theocharous

Reimagining Solid Tumor Immunotherapy Through Engineered Tregs with CoRegen's Dr. Sonal Gupta

Rewriting the Playbook for Stargardt Disease with Atsena Therapeutics' Shannon Boye, Ph.D.

How Precision Oncology Is Redefining Cancer Drug Development with Aprea Therapeutics' Dr. Oren Gilad

Exploring Dendritic Cell Therapy for Solid Tumors with Diakonos Oncology's Jay Hartenbach

Cell & Gene: The Podcast Presents: Better Biopharma's Editors' Roundtable — A Midyear Look at the 2026 Life Sciences Industry

Why In Vivo Therapies Are Moving Toward the Clinic with Ascidian Therapeutics' Dr. Mike Ehlers

Reimagining In Vivo Gene Editing Through Base Editing and Targeted Delivery with Beam Therapeutics' Gopi Shanker, Ph.D.

Advancing CAR T for Drug-Free Remission in Autoimmune Disease with Kyverna Therapeutics' Dr. Naji Gehchan

The Future of In Vivo Gene Editing and Clinical Translation with Precision Biosciences' Cassie Gorsuch, Ph.D.

Redefining CAR-T Timing and Patient Access with Allogene Therapeutics' Dr. Zachary Roberts

Building Integrated cGMP Systems for Autologous Cell Therapies with MassGen's Tatyana Matveeva, Ph.D.